Kishore Hari

Mr. Kishore Hari

Indian Institute of Science, Bangalore
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2022 in eLife
Verified
Journal Article
Open access
KHKishore Hari
Kishore Hari
VUVarun Ullanat
Varun Ullanat
ABArchana Balasubramanian
Archana Balasubramanian
AGAditi Gopalan
Aditi Gopalan
MJMohit Kumar Jolly
Mohit Kumar Jolly
Elucidating the design principles of regulatory networks driving cellular decision-making has fundamental implications in mapping and eventually controlling cell-fate decisions. Despite being complex, these regulatory networks often only give rise to a few phenotypes. Previously, we identified two ‘teams’ of nodes in a small cell lung cancer regulatory network that constrained the phenotypic repertoire and aligned strongly with the dominant phenotypes obtained from network simulations (Chauhan et al., 2021). However, it remained elusive whether these ‘teams’ exist in other networks, and how do they shape the phenotypic landscape. Here, we demonstrate that five different networks of varying sizes governing epithelial–mesenchymal plasticity comprised of two ‘teams’ of players – one comprised of canonical drivers of epithelial phenotype and the other containing the mesenchymal inducers. These ‘teams’ are specific to the topology of these regulatory networks and orchestrate a bimodal phenotypic landscape with the epithelial and mesenchymal phenotypes being more frequent and dynamically robust to perturbations, relative to the intermediary/hybrid epithelial/mesenchymal ones. Our analysis reveals that network topology alone can contain information about corresponding phenotypic distributions, thus obviating the need to simulate them. We propose ‘teams’ of nodes as a network design principle that can drive cell-fate canalization in diverse decision-making processes.

22 April 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AIArvind Iyer
Arvind Iyer
KGKrishan Gupta
Krishan Gupta
SSShreya Sharma
Shreya Sharma
KHKishore Hari
Kishore Hari
YLYi Fang Lee
Yi Fang Lee
Debarka SenguptaDebarka Sengupta
Debarka Sengupta
We collated publicly available single-cell expression profiles of circulating tumor cells (CTCs) and showed that CTCs across cancers lie on a near-perfect continuum of epithelial to mesenchymal (EMT) transition. Integrative analysis of CTC transcriptomes also highlighted the inverse gene expression pattern between PD-L1 and MHC, which is implicated in cancer immunotherapy. We used the CTCs expression profiles in tandem with publicly available peripheral blood mononuclear cell (PBMC) transcriptomes to train a classifier that accurately recognizes CTCs of diverse phenotype. Further, we used this classifier to validate circulating breast tumor cells captured using a newly developed microfluidic system for label-free enrichment of CTCs.

27 April 2020 in Human Molecular Genetics
Verified
Journal Article
Open access
MKMaithilee Khot
Maithilee Khot
DSDyuthi Sreekumar
Dyuthi Sreekumar
SJSanika Jahagirdar
Sanika Jahagirdar
AKApoorva Kulkarni
Apoorva Kulkarni
KHKishore Hari
Kishore Hari
KSKundan Sengupta
Kundan Sengupta
Twist1 is a basic helix-loop-helix transcription factor, essential during early development in mammals. While Twist1 induces epithelial-to-mesenchymal transition (EMT), here we show that Twist1 overexpression enhances nuclear and mitotic aberrations. This is accompanied by an increase in whole chromosomal copy number gains and losses, underscoring the role of Twist1 in inducing chromosomal instability (CIN) in colorectal cancer cells. Array comparative genomic hybridization (array CGH) analysis further shows sub-chromosomal deletions, consistent with an increased frequency of DNA double strand breaks (DSBs). Remarkably, Twist1 overexpression downmodulates key cell cycle checkpoint factors—Bub1, BubR1, Mad1 and Mad2—that regulate CIN. Mathematical simulations using the RACIPE tool show a negative correlation of Twist1 with E-cadherin and BubR1. Data analyses of gene expression profiles of patient samples from The Cancer Genome Atlas (TCGA) reveal a positive correlation between Twist1 and mesenchymal genes across cancers, whereas the correlation of TWIST1 with CIN and DSB genes is cancer subtype-specific. Taken together, these studies highlight the mechanistic involvement of Twist1 in the deregulation of factors that maintain genome stability during EMT in colorectal cancer cells. Twist1 overexpression enhances genome instability in the context of EMT that further contributes to cellular heterogeneity. In addition, these studies imply that Twist1 downmodulates nuclear lamins that further alter spatiotemporal organization of the cancer genome and epigenome. Notwithstanding their genetic background, colorectal cancer cells nevertheless maintain their overall ploidy, while the downstream effects of Twist1 enhance CIN and DNA damage enriching for sub-populations of aggressive cancer cells.

18 April 2022 in Physical Biology
Verified
Journal Article
Open access
JFJasmine Foo
Jasmine Foo
DBDavid Basanta
David Basanta
RRRussell Rockne
Russell Rockne
CSCarly Strelez
Carly Strelez
CSCurran Shah
Curran Shah
Alexander AndersonAlexander Anderson
Alexander Anderson
The role of plasticity and epigenetics in shaping cancer evolution and response to therapy has taken center stage with recent technological advances including single cell sequencing. This roadmap article is focused on state-of-the-art mathematical and experimental approaches to interrogate plasticity in cancer, and addresses the following themes and questions: is there a formal overarching framework that encompasses both non-genetic plasticity and mutation-driven somatic evolution? How do we measure and model the role of the microenvironment in influencing/controlling non-genetic plasticity? How can we experimentally study non-genetic plasticity? Which mathematical techniques are required or best suited? What are the clinical and practical applications and implications of these concepts?

21 December 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
ANArin Nam
Arin Nam
AMATISH MOHANTY
ATISH MOHANTY
Supriyo BhattacharyaSupriyo Bhattacharya
Supriyo Bhattacharya
SKsourabh kotnala
sourabh kotnala
SASrisairam Achuthan
Srisairam Achuthan
Ravi SalgiaRavi Salgia
Ravi Salgia
Drug resistance, a major challenge in cancer therapy, is typically attributed to mutations and genetic heterogeneity. Emerging evidence suggests that dynamic cellular interactions and group behavior also contribute to drug resistance. However, the underlying mechanisms remain poorly understood. Here, we present a new mathematical approach with game theoretical underpinnings that we developed to model real-time growth data of non-small cell lung cancer (NSCLC) cells and discern patterns in response to treatment with cisplatin. We show that the cisplatin-sensitive and cisplatin-tolerant NSCLC cells, when co-cultured in the absence or presence of the drug, display dynamic group behavior strategies. Tolerant cells exhibit a ‘persister-like’ behavior and are attenuated by sensitive cells; they also appear to ‘educate’ sensitive cells to evade chemotherapy. Further, tolerant cells can switch phenotypes to become sensitive, especially at low cisplatin concentrations. Finally, switching treatment from continuous to an intermittent regimen can attenuate the emergence of tolerant cells, suggesting that intermittent chemotherapy may improve outcomes in lung cancer.

2 January 2025 in iScience
Verified
Journal Article
Open access
KHKishore Hari
Kishore Hari
PHPradyumna Harlapur
Pradyumna Harlapur
ASAashna Saxena
Aashna Saxena
KHKushal Haldar
Kushal Haldar
AGAishwarya Girish
Aishwarya Girish
MJMohit Kumar Jolly
Mohit Kumar Jolly
Cell-fate decisions involve coordinated genome-wide expression changes, typically leading to a limited number of phenotypes. Although often modeled as simple toggle switches, these rather simplistic representations often disregard the complexity of regulatory networks governing these changes. Here, we unravel design principles underlying complex cell decision-making networks in multiple contexts. We show that the emergent dynamics of these networks and corresponding transcriptomic data are consistently low-dimensional, as quantified by the variance explained by principal component 1 (PC1). This low dimensionality in phenotypic space arises from extensive feedback loops in these networks arranged to effectively enable the formation of two teams of mutually inhibiting nodes. We use team strength as a metric to quantify these feedback interactions and show its strong correlation with PC1 variance. Using artificial networks of varied topologies, we also establish the conditions for generating canalized cell-fate landscapes, offering insights into diverse binary cellular decision-making networks.